Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells

Background

Cisplatin (CSP) is a potent anticancer drug widely used in treating glioblastoma multiforme (GBM). However, CSP's clinical efficacy in GBM contrasted with low therapeutic ratio, toxicity, and multidrug resistance (MDR). Therefore, we have developed a system for the active targeting of cisplatin in GBM via cisplatin loaded polymeric nanoplatforms (CSP-NPs).

Methods

CSP-NPs were prepared by modified double emulsion and nanoprecipitation techniques. The physiochemical characterizations of CSP-NPs were performed using zeta sizer, scanning electron microscopy (SEM), drug release kinetics, and drug content analysis. Cytotoxicity, induction of apoptosis, and cell cycle-specific activity of CSP-NPs in human GBM cell lines were evaluated by MTT assay, fluorescent microscopy, and flow cytometry. Intracellular drug uptake was gauged by fluorescent imaging and flow cytometry. The potential of CSP-NPs to inhibit MDR transporters were assessed by flow cytometry-based drug efflux assays.

Results

CSP-NPs have smooth surface properties with discrete particle size with required zeta potential, polydispersity index, drug entrapment efficiency, and drug content. CSP-NPs has demonstrated an ‘initial burst effect’ followed by sustained drug release properties. CSP-NPs imparted dose and time-dependent cytotoxicity and triggered apoptosis in human GBM cells. Interestingly, CSP-NPs significantly increased uptake, internalization, and accumulations of anticancer drugs. Moreover, CSP-NPs significantly reversed the MDR transporters (ABCB1 and ABCG2) in human GBM cells.

Conclusion

The nanoparticulate system of cisplatin seems to has a promising potential for active targeting of cisplatin as an effective and specific therapeutic for human GBM, thus eliminating current chemotherapy's limitations.

Impact of nanoparticle inclusion on bioethanol production process kinetic and inhibitor profile

•

NiO nanoparticle (NP) inclusion enhanced bioethanol production up to 59.96 %.

•

Band energy gap impact NP catalytic performance in bioethanol production.

•

NiO nanoparticle biocatalyst improved bioethanol productivity by 145 %.

•

Modified Gompertz model was used to describe ethanol production with NP inclusion.

•

Metallic NiO nanoparticles significantly reduced acetic acid concentration by 110 %.

This study examines the effects of nanoparticle inclusion in instantaneous saccharification and fermentation (NIISF) of waste potato peels. The effect of nanoparticle inclusion on the fermentation process was investigated at different stages which were: pre-treatment, liquefaction, saccharification and fermentation. Inclusion of NiO NPs at the pre-treatment stage gave a 1.60-fold increase and 2.10-fold reduction in bioethanol and acetic acid concentration respectively. Kinetic data on the bioethanol production fit the modified Gompertz model (R ² > 0.98). The lowest production lag time (t _L) of 1.56 h, and highest potential bioethanol concentration (P _m) of 32 g/L were achieved with NiO NPs inclusion at different process stages; the liquefaction stage and the pre-treatment phase, respectively. Elevated bioethanol yield, coupled with substantial reduction in process inhibitors in the NIISF processes, demonstrated the significance of point of nanobiocatalysts inclusion for the scale-up development of bioethanol production from potato peels.

MicroRNAs and Xenobiotic Toxicity: An Overview

•

miRNAs are key regulators of gene expression at both transcription and translation.

•

The role of miRNAs in xenobiotic toxicity and its potential as biomarkers are being explored.

•

In spite of numerous studies, the complex mechanism of miRNA biogenesis and its regulation remains unclear.

The advent of new technologies has paved the rise of various chemicals that are being employed in industrial as well as consumer products. This leads to the accumulation of these xenobiotic compounds in the environment where they pose a serious threat to both target and non-target species. miRNAs are one of the key epigenetic mechanisms that have been associated with toxicity by modulating the gene expression post-transcriptionally. Here, we provide a comprehensive view on miRNA biogenesis, their mechanism of action and, their possible role in xenobiotic toxicity. Further, we review the recent in vitro and in vivo studies involved in xenobiotic exposure induced miRNA alterations and the mRNA-miRNA interactions. Finally, we address the challenges associated with the miRNAs in toxicological studies.